BioPlus Co Ltd
KOSDAQ:099430
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BioPlus Co Ltd
Other Current Assets
BioPlus Co Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Other Current Assets
₩4B
|
CAGR 3-Years
123%
|
CAGR 5-Years
97%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Other Current Assets
₩8.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
SD Biosensor Inc
KRX:137310
|
Other Current Assets
₩150.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
124%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Other Current Assets
₩11.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
21%
|
CAGR 10-Years
29%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Other Current Assets
₩909.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Other Current Assets
₩9.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
49%
|
|
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
See Also
What is BioPlus Co Ltd's Other Current Assets?
Other Current Assets
4B
KRW
Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Other Current Assets amounts to 4B KRW.
What is BioPlus Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
97%
Over the last year, the Other Current Assets growth was 201%. The average annual Other Current Assets growth rates for BioPlus Co Ltd have been 123% over the past three years , 97% over the past five years .
